5,6-trans-latanprost
5-Heptenoicacid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-,1-methylethyl ester, (5E)-
CAS: 913258-34-1
Molecular Formula: C26H40O5
5,6-trans-latanprost - Names and Identifiers
5,6-trans-latanprost - Physico-chemical Properties
| Molecular Formula | C26H40O5 |
| Molar Mass | 432.59 |
| Density | 1.093±0.06 g/cm3(Predicted) |
| Boling Point | 583.8±50.0 °C(Predicted) |
| Solubility | Chloroform (Slightly), Methanol (Slightly) |
| Appearance | Oil |
| Color | Colourless |
| pKa | 14.84±0.70(Predicted) |
| Storage Condition | -80°C Freezer |
| Stability | Temperature Sensitive |
5,6-trans-latanprost - Risk and Safety
| HS Code | 2937500000 |
5,6-trans-latanprost - Introduction
5-Heptenoicacid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-,1-methylethyl ester, (5E)-, also known as 5-Heptenoicacid,7-5S-hydroxy3-hydroxy3-hydroxy3-hydroxy3-hydroxy-hydroxy3-hydroxy-hydroxy3-hydroxy-hydroxy3-hydroxy-hydroxy-hydroxy-hydroxy-hydroxy-hydroxy-hydroxy-hydroxy-hydroxy-hydroxy-hydroxy-hydroxy-hydroxy-3hydroxy3-hydroxy-cyclopentyl ((1hydroxy, its chemical structure is (5E)-.
Nature:
-Appearance: colorless or light yellow viscous liquid.
-Molecular formula: C32H46O6.
-Molecular weight: 526.71g/mol.
-Melting point: about 70-75°C.
-Boiling point: about 570°C.
-Solubility: Soluble in organic solvents, such as alcohols and ketones.
Use:
5-Heptenoicacid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-,1-methylethyl ester, (5E)-is a synthetic prostaglandin E1 analog with the ability to lower blood pressure, constrict blood vessels and improve blood circulation. It can be used to treat hypertension, angina and other diseases of the cardiovascular system.
Method:
5-Heptenoicacid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-,1-methylethyl ester, (5E)-can be synthesized by the following steps:
1. First, it is synthesized from decanoic acid and converted into 7-bromoheptanoic acid through reaction.
2. Grignard reaction with 1,3-cyclopentadiene generates 7-heterocyclic butanol.
3. 7-Heterocyclobutanol is converted to 7-bromopentanol by allylation reaction.
4. Subsequently, cyclopentadienoic acid methyl ester is produced by reaction with methyl cyclopenta-1, 3-diene-1-carboxylate.
5. Finally, 5-Heptenoic acid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, 1-methylyl ester, (5E)-is generated by reduction of carboxymethyl ester-.
Safety Information:
Safety studies on 5-Heptenoicacid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-,1-methylethyl ester, (5E)-are relatively limited. Use should follow the correct experimental operating procedures, and observe safe operation and personal protective measures. It is recommended to wear protective gloves, protective glasses and protective mask to ensure good ventilation. Avoid skin contact and inhalation of vapors when using or handling the compound. In case of contact with skin, eyes or swallowing, rinse immediately with plenty of water and seek medical help.
Nature:
-Appearance: colorless or light yellow viscous liquid.
-Molecular formula: C32H46O6.
-Molecular weight: 526.71g/mol.
-Melting point: about 70-75°C.
-Boiling point: about 570°C.
-Solubility: Soluble in organic solvents, such as alcohols and ketones.
Use:
5-Heptenoicacid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-,1-methylethyl ester, (5E)-is a synthetic prostaglandin E1 analog with the ability to lower blood pressure, constrict blood vessels and improve blood circulation. It can be used to treat hypertension, angina and other diseases of the cardiovascular system.
Method:
5-Heptenoicacid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-,1-methylethyl ester, (5E)-can be synthesized by the following steps:
1. First, it is synthesized from decanoic acid and converted into 7-bromoheptanoic acid through reaction.
2. Grignard reaction with 1,3-cyclopentadiene generates 7-heterocyclic butanol.
3. 7-Heterocyclobutanol is converted to 7-bromopentanol by allylation reaction.
4. Subsequently, cyclopentadienoic acid methyl ester is produced by reaction with methyl cyclopenta-1, 3-diene-1-carboxylate.
5. Finally, 5-Heptenoic acid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, 1-methylyl ester, (5E)-is generated by reduction of carboxymethyl ester-.
Safety Information:
Safety studies on 5-Heptenoicacid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-,1-methylethyl ester, (5E)-are relatively limited. Use should follow the correct experimental operating procedures, and observe safe operation and personal protective measures. It is recommended to wear protective gloves, protective glasses and protective mask to ensure good ventilation. Avoid skin contact and inhalation of vapors when using or handling the compound. In case of contact with skin, eyes or swallowing, rinse immediately with plenty of water and seek medical help.
Last Update：2024-04-10 22:29:15
Supplier List
Spot supply
Product Name: Latanoprost Impurity 2 (5-trans-Latanoprost) Visit Supplier Webpage Request for quotationCAS: 913258-34-1
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
Spot supply
Product Name: Latanoprost Impurity 2 (5-trans-Latanoprost) Visit Supplier Webpage Request for quotationCAS: 913258-34-1
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
View History